Lipid-Based Nanomedicines for Type-Specific Ovarian CancerLipid-Based Nanomedicines for Type-Specific Ovarian Cancer

Epithelial ovarian cancers are currently all treated with the same chemotherapeutic regimen, but delivery via lipid-based nanoparticles has the potential to allow greater specificity by cancer subtype. Nanomedicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news